<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Carpenter, Esme</style></author><author><style face="normal" font="default" size="100%">Buckley, Paul</style></author><author><style face="normal" font="default" size="100%">Alaguthurai, Thanussuyah</style></author><author><style face="normal" font="default" size="100%">Graham, Rosalind</style></author><author><style face="normal" font="default" size="100%">Kakkassery, Helen</style></author><author><style face="normal" font="default" size="100%">Alhity, Gheed</style></author><author><style face="normal" font="default" size="100%">Hossain, Farhana</style></author><author><style face="normal" font="default" size="100%">Mukhtar, Sadiyah</style></author><author><style face="normal" font="default" size="100%">Irshad, Sheeba</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">936 Post neoadjuvant chemotherapy tissues enriched in a distinct CD27&lt;sup&gt;−&lt;/sup&gt;IgD&lt;sup&gt;−&lt;/sup&gt;CD21&lt;sup&gt;-&lt;/sup&gt;CXCR5&lt;sup&gt;-&lt;/sup&gt; atypical double negative (DN)2 B cells, with potential role in purinergic signalling in early breast cancers</style></title><secondary-title><style face="normal" font="default" size="100%">Journal for ImmunoTherapy of Cancer</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2023-11-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">A1040-A1040</style></pages><doi><style  face="normal" font="default" size="100%">10.1136/jitc-2023-SITC2023.0936</style></doi><volume><style face="normal" font="default" size="100%">11</style></volume><issue><style face="normal" font="default" size="100%">Suppl 1</style></issue><abstract><style  face="normal" font="default" size="100%">Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.</style></abstract></record></records></xml>